Ensysce Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ensysce Biosciences, Inc. on February 1, 2023, covering events occurring on January 31, 2023. The filing details a material modification to the rights of security holders involving the declaration of a dividend of Series A Preferred Stock.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance and capital structure changes.
Material Changes
- Series A Preferred Stock Dividend: On January 31, 2023, the Board declared a dividend of 0.001 of a share of Series A Preferred Stock for each outstanding share of Common Stock.
- Record Date: Stockholders of record as of 5:00 pm Eastern Time on February 13, 2023, are eligible for the dividend.
- Voting Rights: Each share of Series A Preferred Stock carries 1,000,000 votes. Consequently, each 0.001 share dividend entitles the holder to 1,000 votes. These shares vote exclusively on a proposed Reverse Stock Split and any related adjournment proposals.
- Transferability: Series A Preferred Stock is uncertificated and may only be transferred in connection with the transfer of Common Stock.
Outlook, Risks, and Unusual Items
- Redemption Terms: Shares of Series A Preferred Stock not present at the meeting to vote on the Reverse Stock Split will be automatically redeemed at the "Initial Redemption Time." Remaining shares will be redeemed upon the effectiveness of the Reverse Stock Split or at the Board's discretion.
- Redemption Consideration: Redemption is paid at a rate of $0.001 in cash for every ten whole shares beneficially owned. Holders of less than ten whole shares receive no cash payment. Fractions are rounded down to the nearest multiple of ten.
- Liquidation Preference: Series A Preferred Stock ranks senior to Common Stock, with a liquidation preference of $0.0001 per share.
- Dividend Rights: Holders of Series A Preferred Stock are not entitled to receive cash dividends.
Investor Verification Checklist
- Verify the specific ratio of the proposed Reverse Stock Split, as the Series A Preferred Stock voting power is designed to influence this outcome.
- Confirm the exact number of Common Stock shares held to calculate the precise number of Series A Preferred Stock shares received (0.001 per Common share).
- Review the Certificate of Designation (Exhibit 3.1) for the full legal definition of "beneficial owner" regarding redemption calculations.
- Monitor the date of the stockholder meeting to determine if shares will be automatically redeemed prior to voting.